TET2 and lung adenocarcinoma: There is also evidence to suggest that a reduction in TET2 protein results in increased angiogenesis in lung adenocarcinoma tumor samples through upregulation of VEGFa transcript, allowing for increased tumor growth and thus driving aggressive disease [80].